Revance Therapeutics Inc (RVNC)
3.07
-0.01
(-0.32%)
USD |
NASDAQ |
Dec 26, 16:00
3.07
0.00 (0.00%)
After-Hours: 17:31
Revance Therapeutics Research and Development Expense (Quarterly): 11.38M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Recursion Pharmaceuticals Inc | 74.60M |
| Regeneron Pharmaceuticals Inc | 1.272B |
| Ligand Pharmaceuticals Inc | 5.675M |
| MEI Pharma Inc | 3.163M |
| Cellectar Biosciences Inc | 5.494M |